Home  /  Latest News  /  BP Telemonitoring Clinical Trial

News & Media

BP Telemonitoring Clinical Trial

From the HealthPartners, Health Improvement1 and the HealthPartners Research Foundation, Minneapolis, MN2 Hypertension is a leading cause of cardiovascular disease and deaths worldwide. Advances in technology have added telemedicine as a tool for managing hypertension.

The effectiveness of telemedicine depends on patients’ ability to adhere to schedules of home monitoring and case management. Participants with uncontrolled hypertension in the intervention arm of a randomized trial who completed 6 months of follow-up were included in this analysis.

Telemonitoring Clinical Trial

They were asked to measure their blood pressure (BP) a minimum of 6 times per week using a telemonitor that transmitted the readings to their pharmacist case manager. Hypertensive patients in this study had high adherence to telemonitoring (73% took at least 6 BP readings per week) and phone visits (88% of expected visits were attended). In a multivariate analysis, older age, male sex, and some college education predicted better telemonitoring adherence. White non-Hispanic race ⁄ ethnicity predicted better adherence to phone visits with pharmacist case managers. Telemonitoring adherence and phone adherence were highly correlated; participants who did not send readings on schedule were more likely

to skip at least one phone visit with their pharmacist case manager. The findings from this analysis indicate that hypertensive patients in this study were able to achieve and maintain high adherence to both the telemonitoring and the phone case management visits.

- J Clin Hypertens (Greenwich). 2012;14:668– 674. 2012 Wiley Periodicals, Inc.

Read the full article on the Telemonitoring clinical trial here